Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Matilainen

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|May 2, 2023
Association of serum neurofilament light with microglial activation in multiple sclerosisMaija Saraste, Markus Matilainen, Anna Vuorimaa, et al.
Therapeutic Advances in Neurological Disorders|August 4, 2025
Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brainTanja Sjöros, Maija Saraste, Markus Matilainen, et al.
Archives of Orthopaedic and Trauma Surgery|August 28, 2024
Changing treatment of hip fractures in FinlandOskari K Leino, Nora Forsbacka, Inari E Laaksonen, et al.
Multiple Sclerosis and Related Disorders|January 21, 2026
Real-world detection of paramagnetic rim lesions and their association with disease burden in multiple sclerosisOlavi Misin, Anni Piispanen, Markus Matilainen, et al.
Frontiers in Neurology|March 6, 2024
Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individualsSini Laaksonen, Maija Saraste, Marjo Nylund, et al.
Parkinsonism & Related Disorders|April 8, 2021
Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's diseaseImran Waggan, Eero Rissanen, Jouni Tuisku, et al.
European Journal of Neurology|May 8, 2023
Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosisJussi Lehto, Marjo Nylund, Markus Matilainen, et al.
Brain : a Journal of Neurology|October 2, 2020
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosisMarcus Sucksdorff, Markus Matilainen, Jouni Tuisku, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026
TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosisMaija Saraste, Taru Nikkilä, Markus Matilainen, et al.
EJNMMI Research|June 2, 2026
The test-retest reproducibility of [<sup>11</sup>C]PK11195 positron emission tomography using Biograph Vision Quadra scannerTanja Sjöros, Markus Matilainen, Virva Saunavaara, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Neurology, Neurosurgery, and Psychiatry|May 2, 2023
Association of serum neurofilament light with microglial activation in multiple sclerosisMaija Saraste, Markus Matilainen, Anna Vuorimaa, et al.
Therapeutic Advances in Neurological Disorders|August 4, 2025
Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brainTanja Sjöros, Maija Saraste, Markus Matilainen, et al.
Archives of Orthopaedic and Trauma Surgery|August 28, 2024
Changing treatment of hip fractures in FinlandOskari K Leino, Nora Forsbacka, Inari E Laaksonen, et al.
Multiple Sclerosis and Related Disorders|January 21, 2026
Real-world detection of paramagnetic rim lesions and their association with disease burden in multiple sclerosisOlavi Misin, Anni Piispanen, Markus Matilainen, et al.
Frontiers in Neurology|March 6, 2024
Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individualsSini Laaksonen, Maija Saraste, Marjo Nylund, et al.
Parkinsonism & Related Disorders|April 8, 2021
Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's diseaseImran Waggan, Eero Rissanen, Jouni Tuisku, et al.
European Journal of Neurology|May 8, 2023
Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosisJussi Lehto, Marjo Nylund, Markus Matilainen, et al.
Brain : a Journal of Neurology|October 2, 2020
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosisMarcus Sucksdorff, Markus Matilainen, Jouni Tuisku, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026
TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosisMaija Saraste, Taru Nikkilä, Markus Matilainen, et al.
EJNMMI Research|June 2, 2026
The test-retest reproducibility of [<sup>11</sup>C]PK11195 positron emission tomography using Biograph Vision Quadra scannerTanja Sjöros, Markus Matilainen, Virva Saunavaara, et al.
Pageof 6